13F filer · CIK 1400240
Flagship Pioneering, LLC
CAMBRIDGE, MA · filing since Q3 2016 · last filing Aug 14, 2026
Reported value
$1.5B
+$378.3M vs prior
Positions
5
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%
Biggest buys vs Q1 2026
No new or increased positions this quarter.
Biggest sells vs Q1 2026
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | GENERATE BIOMEDICINES INCCOM SHS | 62,673,117 | $1.1B | 68.66% |
| 2 | MODERNA INCCOM | 4,632,149 | $324.4M | 21.07% |
| 3 | SANA BIOTECHNOLOGY INCCOM | 25,001,856 | $87.3M | 5.67% |
| 4 | FOGHORN THERAPEUTICS INCCOM | 12,674,120 | $61.8M | 4.02% |
| 5 | SERES THERAPEUTICS INCCOM NEW | 1,155,850 | $9.1M | 0.59% |